Faculty of Medicine

Permanent URI for this communityhttps://repository.ukim.mk/handle/20.500.12188/14

Browse

Search Results

Now showing 1 - 2 of 2
  • Some of the metrics are blocked by your 
    Item type:Publication,
    PREVALENCE OF ANEMIA IN PATIENTS WITH MISSED ABORTION
    (Македонско лекарско друштво = Macedonian medical association, 2025-09)
    ;
    ;
    Jasmina Chelebieva
    ;
    ;
    Bekim Dika
    Introduction: Miscarriage (abortion), 85% of which may happen during the first trimester, is one of the most common adverse pregnancy outcomes. Almost half of miscarriages are a consequence of chromosomal abnormalities. The risk factors include advanced maternal age, comorbidities (obesity, diabetes, hypertension), previous miscarriages, smoking and inappropriate nutritional status. Anaemia is the most prominent haematological abnormality during gestation and it is a global health problem affecting nearly half of all pregnant women. Anaemia has been linked to a higher risk of adverse outcomes, including maternal mortality, stillbirth, preterm births, small-for-gestational-age (SGA). World Health Organization has defined anaemia in pregnancy as the haemoglobin (Hgb) concentration of less than 110g/L. The primary cause of anemia during pregnancy is iron deficiency secondary to chronic inadequate dietary intake and menstruation, heightened by the physiologic demands of the fetus and maternal blood volume expansion during pregnancy. The aim of our study was to determine the prevalence of anemia in women with missed abortion in the first trimester of pregnancy, who are not bleeding. Material and methods: In 80 patients with missed abortion in the first trimester of pregnancy, we determined the level of Hgb in capillary blood. Results: In 31 women (38,8%), we detected anemia (the level of Hgb below 110g/L), and 7 of them (8,8% of the total number of women) had a severe anemia with Hgb levels below 90 g/L. As pregnancy progresses, we expect this prevalence to increase. Conclusion: We want to emphasize that a large percentage of women are anemic even preconceptually and early in pregnancy, so if it is not detected and treated, the severity of anemia worsens as the pregnancy progresses.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    ANEMIA IN PREGNANCY AND RISK FACTORS
    (Македонско лекарско друштво = Macedonian medical association, 2025-09)
    Aleksandar Nakov
    ;
    ;
    ;
    Bekim Dika
    ;
    Introduction: During pregnancy, there is a “dilution” of hemoglobin concentration due to the increase in plasma volume. Iron and folic acid are necessary for the development of the fetus and are transported to it, so the mother can develop anemia due to their deficiency. Anemia affects 36% of pregnant women worldwide. Of those affected, about 40% are due to iron deficiency. Iron is an essential micronutrient involved in vital processes such as erythropoiesis, immune responses, and during pregnancy in the development of the placenta and fetus. The aim of our research was to determine the prevalence of anemia in pregnancy as well as the influence of certain risk factors: age, body mass index - BMI, parity and history of taking iron supplements. Material and methods: A blood count was performed in 100 patients in the third trimester of pregnancy in order to determine the hemoglobin concentration. The patients' body weight and height (to determine BMI) were measured and data were collected about age, number of previous births, and whether they were taking iron supplements. Results: Anemia (hemoglobin level below 110g/L) was present in 42.1% of pregnant women. Anemia was significantly common in women with ≥3 births and in those not taking iron supplements. Statistically insignificant anemia was more common in women under 25 years of age and in those with a BMI below 20. Conclusion: The results of the study showed the importance of regular controls of hemoglobin levels as well as the significance of iron supplementation during pregnancy, when the needs for this element are significantly higher.